Skip to content
Screener

Savara SVRA Net margin

Discontinued — last reported Q4 '20

Net margin at other companies

XER
Xeris Biopharma Holdings, Inc.XERS
-5.1%-1.9pp
Innoviva, Inc. logo
Innoviva, Inc.INVA
81.2%+70.8pp
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
42.8%+38.6pp
Upstream Bio, Inc. logo
Upstream Bio, Inc.UPB
-4,719%+2,752pp
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
11.1%+10.0pp
PVL
Palvella TherapeuticsPVLA
71.7%+40.4pp

Other financials

Income statement

See full
Revenue-—
Operating income-$39.0M-37.1%
Net income-$37.3M-40.0%
EPS (diluted)-$0.15-25.0%

Balance sheet

See full
Cash & equivalents$38.8M+98.4%
Total debt$30.1M+1.8%
Total equity$176.0M+19.1%
Total assets$221.6M+17.1%

Cash flow

See full
Operating cash flow-$33.0M-21.5%
CapEx$54.0K+1,700%
Free cash flow-$33.1M-21.7%

Valuation

See full
Market cap$1.19B+151%
Enterprise value$1.18B+142%

Profitability

See full
Operating margin-19,183.3%—
FCF margin-15,518.7%—

Returns & leverage

See full
Return on equity-80%+4.7pp
Debt / equity0.2×0.0×
Current ratio13.5×-1.4×

Where this comes from

Calculated from Savara’s reported figures.

net income/total revenue=-19,305.1%

Based on trailing twelve months.

The source filing: Savara’s 10-K, filed March 30, 2022. Open the filing →

Filed
Mar 30, 2022, 4:08 PM EDT
Fiscal year
FY2021
Accession
0000950170-22-005045

FAQ

What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.